Cutler Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Cutler Group’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000	Closed	-$1K	–	6216
2021 Q3	$1K	Buy	+1,000	New	+$49.7K	﹤0.01%	5491
2020 Q4	–	Sell	-800	Closed	-$2K	–	5599
2020 Q3	$2K	Buy	+800	New	+$35K	﹤0.01%	4159
2020 Q2	–	Sell	-1,200	Closed	-$2K	–	4990
2020 Q1	$2K	Buy	+1,200	New	+$51.1K	﹤0.01%	3584
2019 Q4	–	Sell	-1,000	Closed	-$2K	–	4718
2019 Q3	$2K	Buy	+1,000	New	+$37.2K	﹤0.01%	3570
2019 Q1	–	Sell	-600	Closed	-$2K	–	4870
2018 Q4	$2K	Buy	+600	New	+$25.6K	﹤0.01%	3466
2018 Q3	–	Sell	-11,300	Closed	-$8K	–	4801
2018 Q2	$8K	Buy	+11,300	New	+$475K	﹤0.01%	2844
2017 Q4	–	Sell	-1,300	Closed	-$1K	–	6095
2017 Q3	$1K	Buy	+1,300	New	+$55.1K	﹤0.01%	5593
2017 Q2	–	Sell	-8,100	Closed	-$7K	–	7205
2017 Q1	$7K	Buy	8,100 +2,000	+33%	+$81.5K	﹤0.01%	4443
2016 Q4	$11K	Buy	6,100 +4,900	+408%	+$199K	﹤0.01%	4133
2016 Q3	$3K	Buy	+1,200	New	+$54.5K	﹤0.01%	5481

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GIA

Gladstone Institutional Advisory Palm Beach Gardens, Florida $2.7B AUM 23.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cutler Group's XPH Position: Q3 2023 in Review

Cutler Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2023, closing a stake of 330 shares — an estimated $13K sold.

Cutler Group first reported a position in XPH in Q1 2016 and held it in 26 quarters. The position peaked at $269K in Q3 2016. 65 funds tracked by Wall St. Rank hold XPH as of Q3 2023.

Cutler Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2023 after selling out during the quarter.
Cutler Group sold 330 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2023, an estimated $13K.
Cutler Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2016 and held it in 26 quarters.
Cutler Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $269K in Q3 2016.
65 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.